Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?The Motley Fool • 04/04/24
Viking Therapeutics Stock Has 72% Upside, According to 1 Wall Street AnalystThe Motley Fool • 04/01/24
Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss DataSeeking Alpha • 03/31/24
Viking Therapeutics' positive results for oral weight-loss drug has analysts backing buy ratingsMarket Watch • 03/27/24
Missed out on Eli Lilly and Novo Nordisk? This pharma stock could be the next ‘big thing'Finbold • 03/27/24
Viking Surges After Weight-Loss Pill — A Rival To Novo, Lilly — Beats Expectations In Just 28 DaysInvestors Business Daily • 03/26/24